Enhanced expression of lipocortin-1 as a new immunosuppressive protein in cancer patients and its influence on reduced in vitro peripheral blood lymphocyte response to mitogens

Surgery Today

Volumn 27, Issue 1, 1997, Pages 30-39

  Koseki, Hiroaki ^a   Shiiba, Ken Ichi ^a   Suzuki, Yukimasa ^a   Asanuma, Taku ^a   Matsuno, Seiki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

gastric cancer; immunosuppression in cancer patients; lipocortin 1; mitogen responsiveness; suppressor macrophage

Indexed keywords

CD14 ANTIGEN; CONCANAVALIN A; LIPOCORTIN 1; MITOGENIC AGENT;

ANTIGEN EXPRESSION; ARTICLE; CANCER; CANCER IMMUNOLOGY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONONUCLEAR CELL; STOMACH CANCER;

ANNEXIN A1; ASCITIC FLUID; COLORECTAL NEOPLASMS; HUMANS; MACROPHAGES; MITOGENS; RECEPTORS, CELL SURFACE; RECEPTORS, MITOGEN; STOMACH NEOPLASMS;

EID: 0031021569     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01366936     Document Type: Article

References (33)

1. Sakata T, Iwagami S, Tsuruta Y, Teraoka U, Hojo K, Suzuki S, Sato K, Suzuki R (1940) The role of lipocortin 1 in macrophage-mediated immunosuppression in tumor-hearing mice. J Immunol 145:387-398
2. Fauci AS, Dale DC, Balow JE (1976) Glucocorticoid therapy: mechanisms of action and clinical considerations. Ann Int Med 84:304-315
3. Flower RJ, Blackwell GJ (1979) Anti-inflammatory steroids induce biosynthesis of phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456-439
4. Blackwell GJ, Cranuccio R, Di Rosa M, Flower RJ, Parente L, Persico P (1980) Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287:147-149
5. Hirata F, Schiffmann E, Venkatasubramanian K, Salomon D, Axelrod J (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 77:2533-2536
6. Hirata F (1981) The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 256:7730-7733
7. Hirata F, Del Carmine R, Nelson CA, Axelrod J, Schiffmann E, Warabi A, Blas AL, Nirenberg M, Manganiello V, Vaughan M, Kumagai S, Green I, Decker JL, Steinberg AD (1981) Presence of auto-antibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci USA 78:3190-3194
8. Hirata F, Iwata M (1983) Role of lipomodulin, phospholipase inhibitory protein, in immunoregulation by thymocytes. J Immunol 130:1930-1936
9. Ueda T, Flirata F, Hirashima M, Ishizaka K (1983) Modulation of the biologic activities of IgE-binding factors: I. Identification of glycosylation-inhibiting factors as a fragment of lipomodulin. J Immunol 130:876-884
10. Cloix JF, Colard O, Rothhut B, Russo MF (1983) Characterization and partial purification of renocortins, two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids. Br J Pharmacol 79:313-321
11. Di Rosa M, Flower RJ, Hirata F, Parente L, Russo MF (1983) Nomenclature announcement: Anti-phospholipase proteins. Prostaglandins 28:441
12. Hirata F, Notsu Y, Iwata M, Parente L, Di Rosa M, Flower RJ (1982) Identification of several species of phospholipase inhibitory protein by radio-immunoassay for lipomodulin. Biochem Biophys Res Commun 109:223-230
13. Rothhut B, Russo MF, Wood J, Di Rosa M, Flower RJ (1983) Futher characterization of the glucocorticoid-induced anti-phospholipase protein "renocortin". Biochem Biophys Res Commun 117:878-884
14. Hattori T, Hirata F, Hoffman T, Hizuta A, Herberman RD (1983) Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulins, a phospholipase inhibitory protein. J Immunol 131:662-665
15. Hirata F (1984) Roles of lipomodulin: A phospholipase inhibitory protein in immunoregulation. In: Otterness I. et al. Advances in inflammation research, vol 7. Raven, New York, pp 71-78
16. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 22:680-686
17. Boyum A (1968) Separation of lymphocytes and erythrocytes by centrifugation. Scand J Clin Invest 21:77-82
18. Kuribayashi K (1976) Immunological experiment techniques V (in Japanese). The Japanese Society for Immunology, Tokyo, Janpan, p 1461
19. Huang HS, Wallner BP, Mattaliano RJ, Tizard R, Sinclair LK, Foeller C, Chow EP, Browning IF, Ramaschandran KL, Tang J, Smart JE, Pepinsky RB (1986) Two human 35kd inhibitors of phospholipase A2 are related to substrates of pp 60v-src and of the epidermal growth factor receptor/kinase. Cell 46:191-199
20. Hirata F (1987) Lipocortins and immune system. Med Immunol 13:523-530
21. Zokas L, Glenny Jr JR (1987) The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: studies using monoclonal antibodies to calpactin subunits. J Cell Biol 105:2111-2121
22. Urushizaki I (1983) Cancer and immune deficiency (in Japanese). Men-eki to Sikkan (Immunol Dis) 6:825-830
23. Whittacker MG, Ress K, Clark CG (1971) Reduced lymphocyte transformation in breast cancer. Lancet 1:892-893
24. Roth JA, Golub SH, Grimn EA, Eilher FR, Morton DL (1976) Effect of operation on in vitro lymphocyte function. Surgery 79:46-51
25. Zembala M, Mytar B, Popiela T, Asherson GL (1977) Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: The role of suppressor cells. Int J Cancer 19:605-613
26. Vose BM, Moore M (1980) Heterogeneity of suppressors of mitogen responsiveness in human malignancy. Cancer Immunol Immunother 9:163-171
27. Tamura K, Shibata Y, Matsuda Y, Ishida N (1981) Isolation and characterization of an immunosuppressive acid protein (IAP) from ascites of cancer patients. Cancer Res 41:3244-3252
28. Toge T, Ikeda H, Senou N (1976) Lymphocyte responsiveness to PHA and serum inhibitory effects in patients with gastric cancer. Jpn J Surg 6:157-162
29. Toge T, Tanada M, Yajima H, Kohno H, Itagaki E, Hattori T (1983) Induction of suppressor cell activity in normal lymphocytes by sera from gastric cancer patients. Clin Exp Immunol 54:80-86
30. Goulding NJ, Luying P, Guyre PM (1990) Characteristic of lipocortin 1 binding to the surface of human peripheral blood leucocytes. Biochem Soc Trans 18:1237-1238
31. Masuda T (1986) Lymphokines (in Japanese). Kodansha, Tokyo, p61
32. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Xiao-Fel Li, Shimizu J, Fujiwara H, Hamaoka T (1991) Transforming growth factor-β-induced inhibition of T cell function. J Immunol 146:1077-1082
33. Moore KW, O'Garra A, Malefyl RW, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190